Related Experiment Video
Updated: May 4, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Disturbed vesicular trafficking of membrane proteins in prion disease
Keiji Uchiyama1, Hironori Miyata2, Suehiro Sakaguchi1
1Division of Molecular Neurobiology; The Institute for Enzyme Research (KOSOKEN); The University of Tokushima; Tokushima, Japan.
Abstract:
The pathogenic mechanism of prion diseases remains unknown. We recently reported that prion infection disturbs post-Golgi trafficking of certain types of membrane proteins to the cell surface, resulting in reduced surface expression of membrane proteins and abrogating the signal from the proteins. The surface expression of the membrane proteins was reduced in the brains of mice inoculated with prions, well before abnormal symptoms became evident. Prions or pathogenic prion proteins were mainly detected in endosomal compartments, being particularly abundant in recycling endosomes. Some newly synthesized membrane proteins are delivered to the surface from the Golgi apparatus through recycling endosomes, and some endocytosed membrane proteins are delivered back to the surface through recycling endosomes. These results suggest that prions might cause neuronal dysfunctions and cell loss by disturbing post-Golgi trafficking of membrane proteins via accumulation in recycling endosomes. Interestingly, it was recently shown that delivery of a calcium channel protein to the cell surface was impaired and its function was abrogated in a mouse model of hereditary prion disease. Taken together, these results suggest that impaired delivery of membrane proteins to the cell surface is a common pathogenic event in acquired and hereditary prion diseases.
Insights
Prion diseases disrupt cell surface protein transport, impairing neuronal function before symptoms appear. This mechanism involves prions accumulating in recycling endosomes, affecting protein delivery in both acquired and hereditary forms.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- The pathogenic mechanisms underlying prion diseases are not fully understood.
- Prion infections are known to disrupt cellular processes, but the specific molecular pathways involved require elucidation.
Purpose of the Study:
- To investigate the role of post-Golgi trafficking in prion disease pathogenesis.
- To determine if impaired membrane protein surface expression is a common feature of prion diseases.
Main Methods:
- Analysis of membrane protein trafficking in prion-infected mouse models.
- Localization studies of prions and pathogenic prion proteins within cellular compartments.
- Comparison of trafficking defects in acquired and hereditary prion disease models.
Main Results:
- Prion infection impairs post-Golgi trafficking of membrane proteins, reducing their surface expression.
- Reduced surface expression of membrane proteins occurs before the onset of clinical symptoms in prion-infected mice.
- Prions accumulate in endosomal compartments, particularly recycling endosomes, disrupting protein transport pathways.
- Impaired delivery of membrane proteins to the cell surface is observed in both acquired and hereditary prion disease models.
Conclusions:
- Prions may cause neuronal dysfunction and loss by disturbing post-Golgi membrane protein trafficking through accumulation in recycling endosomes.
- Impaired delivery of membrane proteins to the cell surface is a shared pathogenic event in acquired and hereditary prion diseases.
Related Concept Videos
Vesicular Tubular Clusters
With the help of motor proteins such...
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Fusion of Secretory Vesicles with the Plasma Membrane
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
Export of Misfolded Proteins out of the ER
Subviral Agents

